INFO CENTER
« Cases and Current InvestigationsVioxx
March 2009Vioxx, the trade name of the generic drug rofecoxib, is a Coz-2 inhibitor, manufactured by Merck & Co., Inc. (Merck). It was approved by the U.S. Food and Drug Administration in 1999 for the treatment of osteoarthritis, menstrual pain and the management of acute pain in adults. Experts raised concerns about the safety of Vioxx as far back as 1999, when Merck's own testing revealed a significantly higher number of heart attacks and strokes than a competitor.
On September 30, 2004, Merck announced that it was voluntarily withdrawing Vioxx from the market worldwide, due to increased risks of cardiovascular problems (including heart attacks and strokes) in users of the drug after these injuring were reported in a three-year clinical study of the drug.
If you have taken Vioxx and have questions about a potential claim, please the Hausfeld LLP attorneys working on the matter, Richard S. Lewis or James J. Pizzirusso.
Practice Areas: Mass Torts
